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Background and purpose — Trabecular metal (TM) cups have 
demonstrated favorable results in acetabular revision and their 
use in primary total hip arthroplasty (THA) is increasing. Some 
evidence show that TM cups might decrease periprosthetic infec-
tion (PPI) incidence. We compared the survivorship of TM cups 
with that of other uncemented cups in primary THA, and evalu-
ated whether the use of TM cups is associated with a lower risk 
of PPI.
Patients and methods — 10,113 primary THAs with TM cup 
and 85,596 THAs with other uncemented cups from 2 high-qual-
ity national arthroplasty registries were included. The mean fol-
low-up times were 3.0 years for the TM cups and 3.8 years for the 
other uncemented cups.
Results — The overall survivorship up to 8 years for TM cups 
and other uncemented cups was 94.4% and 96.2%, respectively (p 
= < 0.001). Adjusting for relevant covariates in a Cox regression 
model the TM cups had a persistently higher revision risk than 
other uncemented cups (HR = 1.5, 95% CI 1.4–1.7, p = < 0.001). 
There was a slightly higher, though not statistically signifi cant, 
revision rate for PPI in the TM group (1.2, 95% CI 1.0–1.6, p = 
0.09).
Interpretation — Risk of revision for any reason was higher for 
the TM cup than for other uncemented cups in primary THA. In 
contrast to our hypothesis, there was no evidence that the revi-
sion rate for PPI was lower in the TM cup patients. Regardless 
of the promising early and mid-term results for TM cups in hip 
revision arthroplasty, we would like to sound a note of caution on 
the increasing use of the TM design, especially in uncomplicated 
primary THAs, where uncemented titanium cups are considered 
to provide a reliable outcome.
■
Trabecular metal (ZimmerBiomet, Warsaw, IN, USA) is made 
of porous tantalum and has been shown to provide higher 
porosity, increased initial stability, and good bone ingrowth 
qualities (Bobyn et al. 1999, Beckmann et al. 2014). These 
advantages make it an attractive option in both primary and 
revision THA. While TM acetabular components are most 
commonly used in revision THA to manage poor bone quality 
and acetabular bone defects (Jafari et al. 2010, Kremers et al. 
2012, Mohaddes et al. 2015), TM cups have also shown excel-
lent results in primary THA (Baad-Hansen et al. 2011, Howard 
et al. 2011). However, there is a lack of data on whether TM 
cups are indeed a more reliable option for primary THA com-
pared to other uncemented cups. In addition a recent study 
suggested that the use of TM acetabular components in hip 
revision arthroplasty might be protective against subsequent 
failure due to periprosthetic infection (PPI) (Tokarski et al. 
2015). PPI is a devastating complication following THA. 
Infection rates around 1% after primary THA have been 
reported by major national registries (Lindgren et al. 2014, 
Gundtoft et al. 2015, Huotari et al. 2015). The total number of 
primary THAs is increasing and, in addition to this increase, 
studies have shown that the risk for infection has been increas-
ing as well over recent decades (Dale et al. 2009, 2012). 
There is a lack of data on whether TM cups are a more 
reliable option for primary THA compared with other unce-
mented cups. A recent study suggested that the use of TM 
acetabular components in hip revision arthroplasty might be 
protective against subsequent failure due to infection (Tokar-
ski et al. 2015); however, the effect of using a TM cup on 
infection rates following primary THA also remains unknown. 
The purpose of this collaborative registry study was to: 
(a) determine the overall revision rate of TM acetabular 
11545 Malchau D.indd   259 5/3/2018   11:33:05 AM
260 Acta Orthopaedica 2018; 89 (3): 259–264
components used in primary THA and to compare it with that 
of other frequently used uncemented cups;
(b) investigate whether the use of a TM cup in primary THA 
will decrease the risk of early revision due to infection com-
pared with other uncemented cup designs.
Patients and methods
Data for this collaborative registry study were collected from 
the Swedish Hip Arthroplasty Register (SHAR) and the Aus-
tralian Orthopaedic Association National Joint Replacement 
Registry (AOANJRR). SHAR has been collecting data on total 
hip replacements since 1979 and currently has information on 
more than 300,000 primary hip replacements. In Sweden all 
orthopedic units performing hip arthroplasties report to the 
SHAR. The completeness of this register has been reported 
as 99% in primary THA. Descriptive surgical data are com-
pleted on standard forms by the responsible surgical team at 
each center. Several validation steps are performed on a reg-
ular basis. AOANJRR began data collection of total hip and 
knee arthroplasties in 1999, and includes data on more than 
98% of arthroplasty procedures performed nationally since 
2002 (AOANJRR 2016) AOANJRR data are validated against 
patient-level data provided by each state and territory health 
departments in Australia using a sequential, multilevel match-
ing process reaching 94% validation on the initial pass of the 
validation process (AOANJRR n.d.). Data are also matched 
biannually with the National Death Index to obtain informa-
tion on the date of death. In both registries revision is defi ned 
as a new surgical intervention when any part of the implant is 
removed or exchanged. This study includes data starting from 
January 1, 2006, which was the time point when reporting of 
the use of TM cups started in both registers (AOANJRR 2016).
Study population
Between January 2006 and December 2014, 25,451 and 
213,314 operations performed with an uncemented acetabular 
component were reported to the SHAR and the AOANJRR, 
respectively. During this study period 10,113 primary THAs 
performed with a TM design (Trabecular Metal Tantalum or 
Continuum (ZimmerBiomet, Warsaw, IN, USA) were regis-
tered in SHAR (n = 2,796) and AOANJRR (n = 7,317). The 
5 most commonly used uncemented acetabular components 
from each register (uncemented n = 83,596, SHAR n = 13,156, 
AOANJRR n = 70,440) were identifi ed (Table 1). The patient 
selection is described in a fl owchart (Figure 1). 
Characteristics of the study population
The average age of the patients at the time of the primary 
operation was 68 (11–100) years in both groups. There were 
Table 1. Trabecular metal cups and 5 other most commonly used 
uncemented cups in primary THA in AOANJRR and SHAR. Values 
are frequency and (%)
Cup design SHAR AOANJRR
Trident 3,390 (21) 33,704 (43)
Pinnacle 1,113 (7) 18,005 (23)
Trilogy 6,972 (44)   9,335 (12)
Refl ection    4,165 (5)
Allofi t   889 (6)   5,231 (7)
Exceed   792 (5) 
TM  
  Continuum 1,979 (12)   3,858 (5)
  Shell   817 (5)   3,449 (4)
AOANJRR
Uncemented cups reported
during years 2006–2014
n = 213,314
Excluded
Not metal on X-poly
n = 120,919
Metal on X-poly
n = 92,395
Metal on X-poly
n = 17,724
Tantalum cups
n = 7,317
Tantalum cups
n = 2,796
Excluded
Not metal on X-poly
n = 7,727
Excluded
Less frequently used cup designs
n = 14,638
Excluded
Less frequently used cup designs
n = 1,772
Other uncemented cup designs
(5 most frequently used)
n = 70,440
Other uncemented cup designs
(5 most frequently used)
n = 13,156
SHAR
Uncemented cups reported
during years 2006–2014
n = 25,451
Figure 1. Flowchart of patient selection.
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44% and 43% males in the TM and the uncemented control 
groups, respectively (Table 2). Primary osteoarthritis was the 
most common reason for surgery both in the TM group (85% 
of all operations) and in the uncemented control group (87% 
of all operations) (Table 2). 
Operative data
In the TM group, uncemented stems were more frequently 
used (65% of all TM cups) compared with the uncemented 
control group (52% of all uncemented cups).
In the TM group, large femoral heads (> 32 mm) were 
implanted in 40% (n = 4,015) of the cases. The correspond-
ing proportion in the uncemented control group was 26% (n = 
21,603). The average follow-up was 3.0 (0–9) years in the TM 
group and 3.8 (0–9) years in the uncemented control group. 
Statistics
The time to fi rst revision was defi ned using Kaplan–Meier 
estimates of survivorship. Survival curves were excluded 
when numbers at risk in any of the groups were below 100 
cases. All analyses were performed using R statistical soft-
ware (RStudio: Integrated Development for R. RStudio, Inc., 
Boston, MA, USA). The log rank test was used to compare 
survival at 8 years. To reduce the risk of possible selection 
bias towards more diffi cult cases being treated with TM cups 
we adjusted the estimated relative revision risks in the Cox 
regression models performed in the whole study population 
regression analysis is presented with hazard ratio (HR) and 
95% CI. 
Ethics, funding, and potential confl ict of interest 
Ethical approval was obtained from the Local Ethical Review 
Board in Gothenburg, Sweden (669-16 dd 29/09/2016). Date of 
issue September 29, 2016. The AOANJRR has been approved 
to use its own data as Federal Quality Control Activity and 
therefore an individual IRB approval is not needed for publi-
cations on de-identifi ed analysis. No funding directly related 
to this study was received. No competing interests declared.
Results
Implant survival
In Kaplan–Meier analysis, the up to 8-year survivorship of the 
TM group was 94.4% (CI 92.8–96.0) and that of the unce-
mented control group 96.2% (CI 96.0–96.4) (p = < 0.001) 
(Figure 2). After adjustment for age, sex, indication for pri-
mary THA, femoral head size, and stem fi xation, the TM 
group had a 1.5 (CI 1.4–1.7, p = < 0.001) times higher risk for 
revision compared with the uncemented control group. In the 
subgroup analysis, which included only patients with a pri-
mary diagnosis of osteoarthritis, cemented stem, and femoral 
head size 32 mm (total n = 17,532; TM n = 1,222; other unce-
mented cups n = 16,310), TM cups were also revised more 
Table 2. Demographics by registry. Values are frequency and (%) unless otherwise stated 
 SHAR AOANJRR
Data TM Uncemented TM Uncemented
Age, years (SD) 61 (11) 60 (11) 70 (11) 71 (11)
Sex     
 Male 1,448 (52) 6,982 (53) 3,039 (42) 29,311 (42)
 Female 1,348 (48) 6,174 (47) 4,278 (58) 41,129 (58)
Side     
 Left 1,457 (52) 6,921 (53) 3,330 (46) 32,211 (46)
 Right 1,339 (48) 6,235 (47) 3,987 (54) 38,229 (54)
Diagnosis     
 Osteoarthritis 2,311 (83) 11,074 (84) 62,46 (85) 62,003 (88)
 Rheumatoid arthritis 61 (2) 307 (2) 66 (1) 626 (1)
 Fracture or secondary 
    to fracture 88 (3) 455 (3) 382 (5) 4,289 (6)
 Developmental dysplasia 212 (8) 788 (6) 119 (2) 477 (1)
 Osteonecrosis 106 (4) 507 (4) 267 (4) 2,164 (3)
 Others 18 (1) 25 (0.2) 237 (3) 881 (1)
Femoral stem fi xation     
 Uncemented 2,487 (89) 11,347 (86) 4,109 (56) 32,124 (46)
 Cemented 309 (11) 1,797 (14) 3,208 (44) 38,316 (54)
Head size, mm     
 < 32 401 (14) 3,268 (25) 621 (8) 17,525 (25)
 32 1,869 (67) 7,253 (55) 3,207 (44) 33,947 (48)
 > 32 526 (19) 2,635 (20) 3,489 (48) 18,968 (27)
Revised     
 No 2,712 (97) 12,804 (97) 7,041 (96) 68,710 (98)
 Yes 84 (3) 352 (3) 276 (4) 1,730 (2)
Follow-up time, years (SD) 2.0 (1.7) 3.7 (2.5) 3.2 (2.2) 3.9 (2.5)
for age, sex, diagnosis, femoral head size, 
and fi xation of the stem. In addition, all 
analyses were repeated following stratifi -
cation of the study population to include 
only patients with a primary diagnosis of 
osteoarthritis, who received a cemented 
stem, and whose femoral head size was 
32 mm (SHAR, n = 708 and AOANJRR, 
n = 16,824). This was done to remove the 
possibility of confounding by head size, 
stem fi xation, and primary diagnosis. In 
this additional subgroup analysis the esti-
mated relative revision risks were adjusted 
for age and sex. Schoenfeld’s residuals 
were used to control for proportional haz-
ards assumption. The primary outcome in 
all analyses was revision for any reason 
and the secondary outcome was revision 
for periprosthetic infection. Revision was 
described as a change or removal of at 
least 1 component. It is possible that indi-
vidual cup types might interact in different 
ways with the femoral stem component, 
and therefore revisions where the stem 
only was exchanged were also included. 
Survival data are presented as percentages 
with 95% confi dence interval (CI). Cox 
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often than other uncemented cups (HR = 2.3, p = < 0.001, CI 
1.6–3.2). 
Infection
In the TM group, including all TM cups, 79 of all 360 revisions 
were performed due to infection, whereas, in the uncemented 
control group 27% (n = 561) of all revisions were performed 
due to infection (Table 3). There was a slightly higher, though 
not statistically signifi cant, revision rate due to infection in the 
TM group compared with the uncemented control group (HR 
= 1.2, CI 1.0-–1.6, p = 0.09) (Figure 3). In the TM group, in 
33% of cup revisions the stem was revised simultaneously (n 
= 120), whereas in groups of other uncemented cups 41% of 
cup revisions had simultaneous stem revision (n  = 848). 
Discussion 
Since the introduction of trabecular metal in 1997, TM cups 
have shown promising results in acetabular revisions (Sieg-
meth et al. 2009, Jafari et al. 2010, Davies et al. 2011, Skyttä 
et al. 2011, Mohaddes et al. 2015). Mid- to long-term survi-
vorship of TM cups has been promising in primary THAs as 
well, where the use of a TM cup has been increasing lately 
(Macheras et al. 2009, Baad-Hansen et al. 2011, Howard et 
al. 2011, Wegrzyn et al. 2015, De Martino et al. 2016). In this 
collaborative register-based study we found that the risk for 
revision for the TM cups was 50% higher in the unrestricted 
analysis and 128% higher in the restricted analysis than that 
of the 5 most frequently used uncemented cup designs after 
primary THA revision for any reason as the end-point. In addi-
tion, there was weak evidence of association between the use 
of a TM cup and higher risk for revision for PPI compared 
with other uncemented designs. 
Our fi ndings that TM cups have a higher revision rate com-
pared with the control group of other uncemented cups is in 
contrast to some earlier studies. When adjusted for confound-
ing factors in the Cox model, the TM cups still had a 1.5 times 
higher risk for revision for any reason when compared with 
the 5 most commonly used uncemented cup designs. Previ-
ous studies have reported excellent results with tantalum cups 
used in primary THA (Jafari et al. 2010, Noiseux et al. 2014, 
De Martino et al. 2016), or have not found any statistically 
or clinically signifi cant difference in the survival results with 
TM cups compared with uncemented titanium cups in pri-
mary THA (Baad-Hansen et al. 2011, Mohaddes et al. 2015). 
Wegrzyn et al. (2015) presented 100% survivorship for the 
TM cup in a randomized controlled trial at 10 years, and they 
also observed statistically signifi cantly fewer radiolucencies 
around the TM cups compared with other uncemented tita-
nium cups. We were not able to assess radiographs and there-
fore could not study radiolucencies. 
The use of TM cups has been recommended for more 
demanding cases with larger acetabular bone defects because 
of the reliable bone ingrowth observed with this material 
(Bobyn et al. 1999). Although increased use in more com-
plicated primary procedures might be one reason explaining 
Figure 2. Kaplan–Meier survival for TM cups 
and other uncemented cups in primary THA 
with revision for any reason as the end-point. 
95% CI levels presented around the curves in 
light blue and light grey.
Figure 3. Kaplan–Meier survival for TM cups 
and other uncemented cups in primary THA 
with revision for infection as the end-point. 
95% CI levels presented around the curves in 
light blue and light grey.
Table 3. Reasons for revision and type of revision by registry.  Values are frequency and 
(%) unless otherwise stated 
 SHAR AOANJRR
Data TM Uncemented TM Uncemented
Reason for revision     
 Infection 36 (43) 125 (36) 43 (16) 436 (25)
 Fracture 7 (8) 55 (16) 53 (19) 387 (22)
 Dislocation 30 (36) 76 (22) 108 (39) 431 (25)
 Loosening 1 (1) 40 (11) 41 (15) 350 (20)
 Others 10 (12) 56 (16) 31 (11) 126 (7)
Type of revision     
 Cup + stem exchange 7 (8) 46 (13) 16 (6) 157 (9)
 Stem exchange 16 (19) 95 (27) 81 (29) 550 (32)
 Cup exchange 7 (8) 60 (17) 50 (18) 293 (17)
 Liner +/- head exchange 38 (45) 78 (22) 80 (29) 511 (30)
 Femoral head exchange 11 (13) 24 (7) 14 (5) 72 (4)
 Extraction 2 (2) 8 (2) 15 (5) 106 (6)
 Others 3 (4) 42 (12) 20 (7) 41 (2)
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the higher overall and infection revision rate of the TM cups 
found in this study, the evidence we have indicates that the use 
of these devices in Sweden and Australia has largely been in 
routine primary procedures. To verify this, we looked at the 
distribution of use by hospital in Sweden and by surgeon in 
Australia. In Sweden 28% of hospitals performing 40 or more 
uncemented primary cups per year used TM in at least 30% of 
all cases. In Australia 22% of surgeons have used a TM cup. 
For surgeons doing more than 25 procedures a year almost 
14% use the TM cup in over 50% of their procedures and 11% 
use it in over 75%. Despite its reputation of being a specialty 
cup, in practice it is being used in these countries as a routine 
cup. Our results may indicate that this is not a benefi cial trend 
from either the cost point of view or more importantly the out-
come. However, TM cups used with large bone defi ciencies in 
revision surgery have been reported to have excellent results 
(Weeden and Schmidt 2007, Sternheim et al. 2012). We do not 
recommend that our results be extrapolated to either complex 
primary or revision surgery. 
Reducing the rate of infection remains an important impera-
tive in joint replacement surgery. In a recent study by Tokarski 
et al. (2015), TM cups used for fi rst-time cup revisions showed 
lower second revision rate for infection than titanium cups. The 
risk of second revision due to infection in cases revised due 
to infection was substantially lower with a tantalum cup than 
with a titanium cup (3% vs. 18%, respectively). The authors 
commented that this might be due to better osteointegration or 
directly associated with tantalum’s biological properties. The 
data from our study indicate that if there is a benefi cial effect 
of TM with respect to infection risk it is not evident when used 
for routine primary procedures. There was, in fact, a slightly 
higher revision rate due to PPI in the TM group compared 
with other uncemented cups, but this was not statistically sig-
nifi cant (p = 0.09). As previously stated, TM cups have been 
recommended for use in more complex primary procedures. 
It is possible to speculate that the trend to increased infection 
may indicate that patients operated on using TM cups in this 
study may have been at a greater risk for infection; however, 
we have no evidence for this. At the very least it can be stated 
that in this large population-based study we have not been able 
to confi rm that there is a benefi cial effect on infection risk 
when TM cups are used in primary procedures. 
We acknowledge a number of limitations in this study, 
the most important being the potential for confounding. Our 
major concern was that TM cups might be selectively used in 
more demanding cases. A number of approaches were taken to 
address this, including the adjustments used in the regression 
analyses as well as in the subgroup analysis. There are, how-
ever, a number of other reasons why we believe that selection 
bias is not a major factor in this study. During the study period 
2006–2014, over 10% of all uncemented cups used in primary 
THA were TM cups. The use of the TM cup has also rapidly 
increased with a 5-fold increase during the study period. The 
TM is clearly a commonly used acetabular component with 
use comparable to other commonly used cementless acetabu-
lar components, indicating frequent use in routine procedures. 
The lack of radiological data and patient-reported outcome 
measures, usual for large registry-based studies, is a further 
limitation. It is likely that there are unrevised patients in both 
groups with pain and/or poor function. Although revision is an 
excellent primary outcome measure for large population-based 
studies, the number of patients with unsatisfactory results will 
be larger than the revised population. There is no reason, how-
ever, to suspect that the indications for revision vary between 
the different populations. Another possible problem in registry 
collaboration is aggregating data from individual registries. 
Nonetheless, due to the similar data structure in both SHAR 
and AOANJRR we are not concerned about combining data 
in this study. 
Although the maximum follow-up of this study is 9 years, 
the mean follow-up time is 3 years. This in part refl ects the 
increased use of these devices in both Sweden and Australia 
in recent years. Risk of revision due to dislocation or infection 
is highest during the fi rst 2 years after primary THA (Pulido 
et al. 2008, Jameson et al. 2011). This is well covered by the 
mean follow-up of this study. Determining the long-term out-
comes of TM cups requires studies with longer follow-up.
In summary, we found the early and mid-term revision rate of 
TM cups is signifi cantly higher than that of other uncemented 
cups in primary THA. Further, there was no statistically sig-
nifi cant difference in revision rate for infection between these 
2 groups. Although TM cups may be a good option in complex 
primary or revision hip arthroplasty, there does not appear to 
be any reason to use TM cups in routine primary THAs, where 
uncemented titanium cups provide patients with a good and 
reliable outcome.
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